Eko Health

Eko Devices’ digital heart disease monitoring system is an all-in-one, non-invasive, cardiopulmonary screening platform. The system connects artificial intelligence (AI) algorithms powering heart sound and EKG sensors to a comprehensive database of cardiopulmonary disease readings. With this technology medical practitioners can accurately detect, and more confidently diagnose and manage treatment to provide patients with the best care possible. The highly sensitive clinical-grade sensors improve diagnoses of cardiopulmonary issues by enhancing medical practitioners’ abilities to hear extremely delicate heart and lung conditions.

With a portfolio of seven FDA-cleared products, the company’s tools open treatment and monitoring opportunities in a multitude of settings such as via telemedicine, emergency medicine, remote care, or in a doctor’s office. The company’s major platform, the CORE technology, is offered as a digital attachment for the normal stethoscope, turning the everyday instrument into a digital tool for the 21st century, or as a digital stethoscope. Eko’s stethoscopes allow, for the first time in history, patient sounds to be integrated with electronics health records (EHRs) for seamless referrals, documentation, and monitoring.

The details below are based on information received from, and verified solely by, the company and/or PROOF our network VC.